MYH9 and triple-negative breast carcinoma: In triple-negative breast cancer, circRNA EIF6-224aa directly interacts with MYH9, inhibiting MYH9 degradation through the ubiquitin-proteasome pathway and activating the Wnt/β-catenin signaling pathway [36].